Elysium Therapeutics Showcases SOOPR Technology to Combat Opioid Overdose Crisis
Elysium Therapeutics Showcases SOOPR Technology to Combat Opioid Overdose Crisis
Introduction
The opioid crisis remains one of the most pressing public health challenges, particularly with the rise of synthetic opioids like fentanyl. Elysium Therapeutics, an innovative biopharmaceutical company, recently conducted an investor webcast emphasizing the urgent need for effective overdose rescue medications. The company’s latest development, the Synthetic Opioid Overdose Prevention and Reversal (SOOPR™) technology, aims to improve the management of overdose incidents involving these potent drugs.
The Fentanyl Crisis
Fentanyl, a powerful synthetic opioid, has been implicated in a significant increase in overdose deaths, particularly among adults aged 18 to 45. Current rescue agents like Narcan® and Opvee® have proven insufficient in many scenarios, as they can lead to a phenomenon known as
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.